Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/AGENUS-INC-8290/noticia/Agenus-Inc-Anuncia-datos-ampliados-del-estudio-de-fase-1b-de-la-compa-a-sobre-botensilimab-en-co-45119822/?utm_source=whatsapp&utm_medium=social&utm_campaign=share